FDA Audits Pulse Oximeter Efficacy To Address Digital Health Bias
Food and Drug Administration FDA to schedule public meeting of Medical Devices Advisory Committee to discuss study results about pulse oximeter performance. Meeting consistent with agency efforts to evaluate clinical trial design transparency, diversity, AI development need.
Michael Sjoding Drug Administration Devices Advisory Committee Medical Devices Advisory Committee Medical Devices Workshop New England Journal
Source: natlawreview.com